Trial Profile
Bimatoprost 0.03% Solution, NB-UVB and Fractional Carbon Dioxide Laser in Treatment of Generalized Vitiligo
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2020
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Vitiligo
- Focus Adverse reactions; Therapeutic Use
- 05 Apr 2018 New trial record